Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Preferred Shares Issued (2021)

Historic Preferred Shares Issued for Vistagen Therapeutics (VTGN) over the last 4 years, with Q1 2021 value amounting to $100.0.

  • Vistagen Therapeutics' Preferred Shares Issued changed N/A to $100.0 in Q1 2021 from the same period last year, while for Mar 2022 it was $4.2 million, marking a year-over-year decrease of 4999.94%. This contributed to the annual value of $93.7 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Vistagen Therapeutics reported Preferred Shares Issued of $100.0 as of Q1 2021.
  • In the past 5 years, Vistagen Therapeutics' Preferred Shares Issued ranged from a high of $100.0 in Q1 2021 and a low of $100.0 during Q1 2021